|
1
|
Keck PJ, Hauser SD, Krivi G, Sanzo K,
Warren T, Feder J and Connolly DT: Vascular permeability factor, an
endothelial cell mitogen related to PDGF. Science. 246:1309–1312.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Y, Mao XO, Xie L, Banwait S, Marti
HH, Greenberg DA and Jin K: Vascular endothelial growth factor
overexpression delays neurodegeneration and prolongs survival in
amyotrophic lateral sclerosis mice. J Neurosci. 27:304–307. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Du Y, Chen Q, Huang L, Wang S, Yin X, Zhou
L, Ye Z, Ren X, Cai Y, Ding X, et al: VEGFR2 and VEGF-C suppresses
the epithelial-mesenchymal transition via YAP in retinal pigment
epithelial cells. Curr Mol Med. 18:273–286. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saint-Geniez M, Maharaj AS, Walshe TE,
Tucker BA, Sekiyama E, Kurihara T, Darland DC, Young MJ and D'Amore
PA: Endogenous VEGF is required for visual function: evidence for a
survival role on müller cells and photoreceptors. PLoS One.
3:e35542008. View Article : Google Scholar
|
|
5
|
Aiello LP, Avery RL, Arrigg PG, Keyt BA,
Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA and Park JE:
Vascular endothelial growth factor in ocular fluid of patients with
diabetic retinopathy and other retinal disorders. N Engl J Med.
331:1480–1487. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gunay BO and Esenulku CM: Retinal nerve
fibre layer and ganglion cell layer thickness changes following
intravitreal aflibercept for age-related macular degeneration.
Cutan Ocul Toxicol. 41:91–97. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arumuganathan N, Wiest MRJ, Toro MD,
Hamann T, Fasler K and Zweifel SA: Acute and subacute macular and
peripapillary angiographic changes in choroidal and retinal blood
flow post-intravitreal injections. Sci Rep. 11:19381"2021.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cheung CMG, Teo KYC, Tun SBB, Busoy JM,
Veluchamy AB and Spaide RF: Differential reperfusion patterns in
retinal vascular plexuses following increase in intraocular
pressure an OCT angiography study. Sci Rep. 10:165052020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gómez-Mariscal M, Muñoz-Negrete FJ and
Rebolleda Fernández G: Effects of intravitreal anti-VEGF therapy on
glaucoma-like progression in susceptible eyes. J Glaucoma.
29:e54–e55. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jonas JB, Budde WM and Panda-Jonas S:
Ophthalmoscopic evaluation of the optic nerve head. Surv
Ophthalmol. 43:293–320. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Alasil T, Wang K, Yu F, Field MG, Lee H,
Baniasadi N, de Boer JF, Coleman AL and Chen TC: Correlation of
retinal nerve fiber layer thickness and visual fields in glaucoma:
A broken stick model. Am J Ophthalmol. 157:953–959. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sugimoto M, Nunome T, Sakamoto R,
Kobayashi M and Kondo M: Effect of intravitreal ranibizumab on the
ocular circulation of the untreated fellow eye. Graefes Arch Clin
Exp Ophthalmol. 255:1543–1550. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reinhard J, Renner M, Wiemann S, Shakoor
DA, Stute G, Dick HB, Faissner A and Joachim SC: Ischemic injury
leads to extracellular matrix alterations in retina and optic
nerve. Sci Rep. 7:434702017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Salminen A, Kauppinen A, Hyttinen JM,
Toropainen E and Kaarniranta K: Endoplasmic reticulum stress in
age-related macular degeneration: Trigger for neovascularization.
Mol Med. 16:535–542. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kruk J, Kubasik-Kladna K and Aboul-Enein
HY: The role oxidative stress in the pathogenesis of eye diseases:
Current status and a dual role of physical activity. Mini Rev Med
Chem. 16:241–257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao G, Li Y, Zhang D, Gee S, Crosson C and
Ma J: Unbalanced expression of VEGF and PEDF in ischemia-induced
retinal neovascularization. FEBS Lett. 489:270–276. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Angayarkanni N, Selvi R, Pukhraj R, Biswas
J, Bhavesh SJ and Tombran-Tink J: Ratio of the vitreous vascular
endothelial growth factor and pigment epithelial-derived factor in
Eales disease. J Ocul Biol Dis Infor. 2:20–28. 2009. View Article : Google Scholar
|
|
18
|
Chen JF, Luo QH, Huang C, Liu WT, Zeng W,
Gao Q, Chen P, Chen B and Chen ZL: Expression of VEGF and PEDF in
early-stage retinopathy in diabetic Macaca mulatta. Nan Fang Yi Ke
Da Xue Xue Bao. 37:1217–1221. 2017.In Chinese. PubMed/NCBI
|
|
19
|
Yamagishi S and Imaizumi T: Diabetic
vascular complications: Pathophysiology, biochemical basis and
potential therapeutic strategy. Curr Pharm Des. 11:2279–2299. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamagishi S, Matsui T, Nakamura K,
Takeuchi M and Imaizumi T: Pigment epithelium-derived factor (PEDF)
prevents diabetes- or advanced glycation end products
(AGE)-elicited retinal leukostasis. Microvasc Res. 72:86–90. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamagishi S, Nakamura K, Matsui T, Inagaki
Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I,
Motomiya Y, et al: Pigment epithelium-derived factor inhibits
advanced glycation end product-induced retinal vascular
hyperpermeability by blocking reactive oxygen species-mediated
vascular endothelial growth factor expression. J Biol Chem.
281:20213–20220. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Seddon JM, Gensler G, Milton RC, Klein ML
and Rifai N: Association between C-reactive protein and age-related
macular degeneration. JAMA. 291:704–710. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hachana S, Fontaine O, Sapieha P, Lesk M,
Couture R and Vaucher E: The effects of anti-VEGF and kinin B (1)
receptor blockade on retinal inflammation in laser-induced
choroidal neovascularization. Br J Pharmacol. 177:1949–1966. 2020.
View Article : Google Scholar :
|
|
24
|
Wang Y, Bian ZM, Yu WZ, Yan Z, Chen WC and
Li XX: Induction of interleukin-8 gene expression and protein
secretion by C-reactive protein in ARPE-19 cells. Exp Eye Res.
91:135–142. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee MY, Park S, Song JY, Ra H, Baek JU and
Baek J: Inflammatory cytokines and retinal nonperfusion area in
quiescent proliferative diabetic retinopathy. Cytokine.
154:1557742022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sato T, Takeuchi M, Karasawa Y, Enoki T
and Ito M: Intraocular inflammatory cytokines in patients with
neovascular age-related macular degeneration before and after
initiation of intravitreal injection of anti-VEGF inhibitor. Sci
Rep. 8:10982018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gong C, Qiao L, Feng R, Xu Q, Zhang Y,
Fang Z, Shen J and Li S: IL-6-induced acetylation of E2F1
aggravates oxidative damage of retinal pigment epithelial cell
line. Exp Eye Res. 200:1082192020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu ZY, Meng YA, Yan B and Luo J: Effect
of anti-VEGF treatment on nonperfusion areas in ischemic
retinopathy. Int J Ophthalmol. 14:1647–1652. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Metelitsina TI, Grunwald JE, DuPont JC,
Ying GS, Brucker AJ and Dunaief JL: Foveolar choroidal circulation
and choroidal neovascularization in age-related macular
degeneration. Invest Ophthalmol Vis Sci. 49:358–363. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arjamaa O, Nikinmaa M, Salminen A and
Kaarniranta K: Regulatory role of HIF-1alpha in the pathogenesis of
age-related macular degeneration (AMD). Ageing Res Rev. 8:349–358.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Feigl B: Age-related maculopathy-linking
aetiology and pathophysiological changes to the ischaemia
hypothesis. Prog Retin Eye Res. 28:63–86. 2009. View Article : Google Scholar
|
|
32
|
Roybal CN, Yang S, Sun CW, Hurtado D, Jagt
DL, Townes TM and Abcouwer SF: Homocysteine increases the
expression of vascular endothelial growth factor by a mechanism
involving endoplasmic reticulum stress and transcription factor
ATF4. J Biol Chem. 279:14844–14852. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Roybal CN, Hunsaker LA, Barbash O, Jagt DL
and Abcouwer SF: The oxidative stressor arsenite activates vascular
endothelial growth factor mRNA transcription by an ATF4-dependent
mechanism. J Biol Chem. 280:20331–20339. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fernandes AF, Guo W, Zhang X, Gallagher M,
Ivan M, Taylor A, Pereira P and Shang F: Proteasome-dependent
regulation of signal transduction in retinal pigment epithelial
cells. Exp Eye Res. 83:1472–1481. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moenner M, Pluquet O, Bouchecareilh M and
Chevet E: Integrated endoplasmic reticulum stress responses in
cancer. Cancer Res. 67:10631–10634. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Feng Y, Wang C and Wang G: Inhibition of
KCTD10 affects diabetic retinopathy progression by reducing VEGF
and affecting angiogenesis. Genet Res (Camb). 2022:41123072022.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Roybal CN, Marmorstein LY, Jagt DL and
Abcouwer SF: Aberrant accumulation of fibulin-3 in the endoplasmic
reticulum leads to activation of the unfolded protein response and
VEGF expression. Invest Ophthalmol Vis Sci. 46:3973–3979. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Axer-Siegel R, Bourla D, Ehrlich R, Dotan
G, Benjamini Y, Gavendo S, Weinberger D and Sela BA: Association of
neovascular age-related macular degeneration and
hyperhomocysteinemia. Am J Ophthalmol. 137:84–89. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ji C: Dissection of endoplasmic reticulum
stress signaling in alcoholic and non-alcoholic liver injury. J
Gastroenterol Hepatol. 23(Suppl 1): S16–S24. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chong EW, Kreis AJ, Wong TY, Simpson JA
and Guymer RH: Alcohol consumption and the risk of age-related
macular degeneration: A systematic review and meta-analysis. Am J
Ophthalmol. 145:707–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim LA and D'Amore PA: A brief history of
anti-VEGF for the treatment of ocular angiogenesis. Am J Pathol.
181:376–379. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wichrowska M, Goździewska E and Kocięcki
J: The safety of Anti-VEGF treatment, in the context of the retinal
nerve fibre layer, in patients with wet age-related macular
degeneration: A review. Front Biosci (Landmark Ed). 28:2222023.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fleckenstein M, Keenan TDL, Guymer RH,
Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, Wong WT and Chew
EY: Age-related macular degeneration. Nat Rev Dis Primers.
7:312021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dugel PU, Koh A, Ogura Y, Jaffe GJ,
Schmidt-Erfurth U, Brown DM, Gomes AV, Warburton J, Weichselberger
A and Holz FG; HAWK and HARRIER: Phase 3, multicenter, randomized,
double-masked trials of brolucizumab for neovascular age-related
macular degeneration. Ophthalmology. 127:72–84. 2020. View Article : Google Scholar
|
|
45
|
Liberski S, Wichrowska M and Kocięcki J:
Aflibercept versus faricimab in the treatment of neovascular
age-related macular degeneration and diabetic macular edema: A
review. Int J Mol Sci. 23:94242022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Falavarjani KG and Nguyen QD: Adverse
events and complications associated with intravitreal injection of
anti-VEGF agents: A review of literature. Eye (Lond). 27:787–794.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tolentino M: Systemic and ocular safety of
intravitreal anti-VEGF therapies for ocular neovascular disease.
Surv Ophthalmol. 56:95–113. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bakri SJ, Pulido JS, McCannel CA, Hodge
DO, Diehl N and Hillemeier J: Immediate intraocular pressure
changes following intravitreal injections of triamcinolone,
pegaptanib, and bevacizumab. Eye (Lond). 23:181–185. 2009.
View Article : Google Scholar
|
|
49
|
Gismondi M, Salati C, Salvetat ML,
Zeppieri M and Brusini P: Short-term effect of intravitreal
injection of Ranibizumab (Lucentis) on intraocular pressure. J
Glaucoma. 18:658–661. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Meyer CH, Michels S, Rodrigues EB, Hager
A, Mennel S, Schmidt JC, Helb HM and Farah ME: Incidence of
rhegmatogenous retinal detachments after intravitreal antivascular
endothelial factor injections. Acta Ophthalmol. 89:70–75. 2011.
View Article : Google Scholar
|
|
51
|
Ganssauge M, Wilhelm H, Bartz-Schmidt KU
and Aisenbrey S: Non-arteritic anterior ischemic optic neuropathy
(NA-AION) after intravitreal injection of bevacizumab (Avastin) for
treatment of angoid streaks in pseudoxanthoma elasticum. Graefes
Arch Clin Exp Ophthalmol. 247:1707–1710. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hosseini H and Razeghinejad MR: Anterior
ischemic optic neuropathy after intravitreal injection of
bevacizumab. J Neuroophthalmol. 29:160–161. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mansour AM, Bynoe LA, Welch JC, Pesavento
R, Mahendradas P, Ziemssen F and Pai SA: Retinal vascular events
after intravitreal bevacizumab. Acta Ophthalmol. 88:730–735. 2010.
View Article : Google Scholar
|
|
54
|
Furino C, Boscia F, Cardascia N, Alessio G
and Sborgia C: Hemorrhagic macular infarction after intravitreal
bevacizumab for central retinal vein occlusion. Ophthalmic Surg
Lasers Imaging. 9:1–2. 2010. View Article : Google Scholar
|
|
55
|
Huang ZL, Lin KH, Lee YC, Sheu MM and Tsai
RK: Acute vision loss after intravitreal injection of bevacizumab
(avastin) associated with ocular ischemic syndrome.
Ophthalmologica. 224:86–89. 2010. View Article : Google Scholar
|
|
56
|
Cakmak HB, Toklu Y, Yorgun MA and Simşek
S: Isolated sixth nerve palsy after intravitreal bevacizumab
injection. Strabismus. 18:18–20. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Damasceno NA, Yannuzzi NA, Maia M, Farah
ME, Flynn HW Jr and Damasceno EF: Transient central retina artery
occlusion in patients undergoing intravitreal anti vegf injections.
Eur J Ophthalmol. 32:2819–2823. 2022. View Article : Google Scholar
|
|
58
|
Wichrowska M, Wichrowski P and Kocięcki J:
Morphological and functional assessment of the optic nerve head and
retinal ganglion cells in dry vs chronically treated wet
age-related macular degeneration. Clin Ophthalmol. 16:2373–2384.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lim HB, Sung JY, Ahn SI, Jo YJ and Kim JY:
Retinal nerve fiber layer thickness in various retinal diseases.
Optom Vis Sci. 95:247–255. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Dikmetas O, Gungor G, Kapucu Y,
Kocabeyoglu S, Kadayıfcılar S, Eldem B, Karahan S and Cankaya AB:
Short-term effect of macular edema on the peripapillary retinal
nerve fiber layer in patients with wet age-related macular
degeneration and diabetic macular edema: A comparative study.
Photodiagnosis Photodyn Ther. 42:1036022023. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Martinez-de-la-Casa JM, Ruiz-Calvo A,
Saenz-Frances F, Reche-Frutos J, Calvo-Gonzalez C, Donate-Lopez J
and Garcia-Feijoo J: Retinal nerve fiber layer thickness changes in
patients with age-related macular degeneration treated with
intravitreal ranibizumab. Invest Ophthalmol Vis Sci. 53:6214–6218.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Jun SY and Hwang DD: Short-term effect of
intravitreal brolucizumab injections in patients with neovascular
age-related macular degeneration on retinal nerve fiber layer
thickness. Sci Rep. 13:66852023. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Valverde-Megías A, Ruiz-Calvo A,
Murciano-Cespedosa A, Hernández-Ruiz S, Martínez-de-la-Casa JM and
García-Feijoo J: Long-term effect of intravitreal ranibizumab
therapy on retinal nerve fiber layer in eyes with exudative
age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol.
257:1459–1466. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Parlak M, Oner FH and Saatci AO: The
long-term effect of intravitreal ranibizumab on retinal nerve fiber
layer thickness in exudative age-related macular degeneration. Int
Ophthalmol. 35:473–480. 2015. View Article : Google Scholar
|
|
65
|
Chauhan BC, Danthurebandara VM, Sharpe GP,
Demirel S, Girkin CA, Mardin CY, Scheuerle AF and Burgoyne CF:
Bruch's membrane opening minimum rim width and retinal nerve fiber
layer thickness in a normal white population: A multicenter study.
Ophthalmology. 122:1786–1794. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Boltz A, Spöttl T, Huf W, Weingessel B and
Vécsei-Marlovits VP: Effect of intravitreal injections due to
neovascular age-related macular degeneration on retinal nerve fiber
layer thickness and minimum rim width: A cross sectional study. BMC
Ophthalmol. 24:1852024. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Law SK, Small KW and Caprioli J:
Peripapillary retinal nerve fiber measurement with spectral-domain
optical coherence tomography in age-related macular degeneration.
Vision (Basel). 1:262017. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ahn J, Jang K, Sohn J, Park JI and Hwang
DD: Effect of intravitreal ranibizumab and aflibercept injections
on retinal nerve fiber layer thickness. Sci Rep. 11:50102021.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Bitirgen G, Belviranli S, Malik RA,
Kerimoglu H, Satirtav G and Zengin N: Assessment of corneal
sensation, innervation and retinal nerve fiber layer in patients
treated with multiple intravitreal ranibizumab injections. PLoS
One. 12:e01702712017. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Demirel S, Batioğlu F, Özmert E and
Erenler F: The effect of multiple injections of ranibizumab on
retinal nerve fiber layer thickness in patients with age-related
macular degeneration. Curr Eye Res. 40:87–92. 2015. View Article : Google Scholar
|
|
71
|
Zucchiatti I, Cicinelli MV, Parodi MB,
Pierro L, Gagliardi M, Accardo A and Bandello F: Effect of
intravitreal ranibizumab on ganglion cell complex and peripapillary
retinal nerve fiber layer in neovascular age-related macular
degeneration using spectral domain optical coherence tomography.
Retina. 37:1314–1319. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
El-Ashry MF, Lascaratos G and Dhillon B:
Evaluation of the effect of intravitreal ranibizumab injections in
patients with neovascular age related macular degeneration on
retinal nerve fiber layer thickness using optical coherence
tomography. Clin Ophthalmol. 9:1269–1274. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Sobacı G, Güngör R and Ozge G: Effects of
multiple intravitreal anti-VEGF injections on retinal nerve fiber
layer and intraocular pressure: A comparative clinical study. Int J
Ophthalmol. 6:211–215. 2013.
|
|
74
|
Horsley MB, Mandava N, Maycotte MA and
Kahook MY: Retinal nerve fiber layer thickness in patients
receiving chronic anti-vascular endothelial growth factor therapy.
Am J Ophthalmol. 150558–561. (e551)2010. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Viggiano P, Buonamassa R, Grassi MO,
Boscia G, Borrelli E, Landini L, Evangelista F, Malerba MG, Alessio
G and Boscia F: Immediate effect of anti-VEGF injections on optic
nerve head: Correlation between intraocular pressure and anatomical
peripapillary changes. Eur J Ophthalmol. 34:1174–1182. 2024.
View Article : Google Scholar
|
|
76
|
Entezari M, Ramezani A and Yaseri M:
Changes in retinal nerve fiber layer thickness after two
intravitreal bevacizumab injections for wet type age-related
macular degeneration. J Ophthalmic Vis Res. 9:449–452. 2014.
View Article : Google Scholar
|
|
77
|
Zivkovic M, Radosavljevic A, Zlatanovic M,
Jaksic V, Davidovic S, Stamenkovic M, Todorovic I and Jaksic J:
Influence of multiple Anti-VEGF injections on retinal nerve fiber
layer and ganglion cell-inner plexiform layer thickness in patients
with exudative age-related macular degeneration. Medicina (Kaunas).
59:1382023. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Klein BE, Klein R and Jensen SC:
Open-angle glaucoma and older-onset diabetes. The beaver dam eye
study Ophthalmology. 101:1173–1177. 1994.
|
|
79
|
Hoguet A, Chen PP, Junk AK, Mruthyunjaya
P, Nouri-Mahdavi K, Radhakrishnan S, Takusagawa HL and Chen TC: The
effect of anti-vascular endothelial growth factor agents on
intraocular pressure and glaucoma: A report by the american academy
of ophthalmology. Ophthalmology. 126:611–622. 2019. View Article : Google Scholar
|
|
80
|
Khodabande A, Zarei M, Khojasteh H,
Mohammadi M, Khameneh EA, Torkashvand A and Davoodabadi M: The
effect of acute rises in intraocular pressure after intravitreal
bevacizumab injection on the peripapillary retinal nerve fiber
layer thickness and the role of anterior chamber paracentesis. J
Curr Ophthalmol. 33:12–16. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Soheilian M, Karimi S, Montahae T, Nikkhah
H and Mosavi SA: Effects of intravitreal injection of bevacizumab
with or without anterior chamber paracentesis on intraocular
pressure and peripapillary retinal nerve fiber layer thickness: A
prospective study. Graefes Arch Clin Exp Ophthalmol. 255:1705–1712.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Levin AM, Chaya CJ, Kahook MY and Wirostko
BM: Intraocular pressure elevation following intravitreal Anti-VEGF
injections: Short- and long-term considerations. J Glaucoma.
30:1019–1026. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Mansoori T, Agraharam SG, Manwani S and
Balakrishna N: Intraocular pressure changes after intravitreal
bevacizumab or ranibizumab injection: A retrospective study. J Curr
Ophthalmol. 33:6–11. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Karakahya RH: Anterior chamber
paracentesis offers a less painful experience during intravitreal
anti-vascular endothelial growth factor administration: An
intraindividual study. Cureus. 13:e200512021.
|
|
85
|
Türksever C, Hoffmann L and Hatz K:
Peripapillary and macular microvasculature in neovascular
age-related macular degeneration in long-term and recently started
anti-VEGF therapy versus healthy controls. Front. Med (Lausanne).
9:10800522023. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Wang L, Swaminathan SS, Yang J, Barikian
A, Shi Y, Shen M, Jiang X, Feuer W, Gregori G and Rosenfeld PJ:
Dose-Response relationship between intravitreal injections and
retinal nerve fiber layer thinning in age-related macular
degeneration. Ophthalmol Retina. 5:648–654. 2021. View Article : Google Scholar
|
|
87
|
Weinreb RN and Khaw PT: Primary open-angle
glaucoma. Lancet. 363:1711–1720. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Sommer A, Miller NR, Pollack I, Maumenee
AE and George T: The nerve fiber layer in the diagnosis of
glaucoma. Arch Ophthalmol. 95:2149–2156. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Cho HK and Kee C: Rate of change in
Bruch's membrane opening-minimum rim width and peripapillary RNFL
in early normal tension glaucoma. J Clin Med. 9:23212020.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Choi HS, Joo CW, Park SP and Na KI: A
decrease in Bruch's membrane opening-minimum rim area precedes
decreased retinal nerve fiber layer thickness and visual field loss
in glaucoma. J Glaucoma. 30:1033–1038. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
LoBue SA, Gindina S, Saba NJ, Chang T,
Davis MJ and Fish S: Clinical features associated with acute
elevated intraocular pressure after intravitreal anti-VEGF
injections. Clin Ophthalmol. 17:1683–1690. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Gómez-Mariscal M, Puerto B, Muñoz-Negrete
FJ, de Juan V and Rebolleda G: Acute and chronic optic nerve head
biomechanics and intraocular pressure changes in patients receiving
multiple intravitreal injections of anti-VEGF. Graefes Arch Clin
Exp Ophthalmol. 257:2221–2231. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Enders P, Sitnilska V, Altay L, Schaub F,
Muether PS and Fauser S: Retinal nerve fiber loss in anti-VEGF
therapy for age-related macular degeneration can be decreased by
anterior chamber paracentesis. Ophthalmologica. 237:111–118. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Ranjbar M, Kurz M, Holzhey A, Rades D and
Grisanti S: Changes in peripapillary nerve fiber layer thickness
after adjuvant stereotactic radiotherapy in patients with
neovascular age-related macular degeneration. Curr Eye Res.
42:1698–1706. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Moshfeghi DM, Kaiser PK and Gertner M:
Stereotactic low-voltage x-ray irradiation for age-related macular
degeneration. Br J Ophthalmol. 95:185–188. 2011. View Article : Google Scholar
|
|
96
|
Ranjbar M, Kurz M, Holzhey A, Melchert C,
Rades D and Grisanti S: Stereotactic radiotherapy in neovascular
age-related macular degeneration: Real-life efficacy and
morphological evaluation of the outer retina-choroid complex.
Medicine (Baltimore). 95:e57292016. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Jackson TL, Chakravarthy U, Slakter JS,
Muldrew A, Shusterman EM, O'Shaughnessy D, Arnoldussen M, Gertner
ME, Danielson L and Moshfeghi DM; INTREPID Study Group:
Stereotactic radiotherapy for neovascular age-related macular
degeneration: Year 2 results of the INTREPID study. Ophthalmology.
122:138–145. 2015. View Article : Google Scholar
|
|
98
|
Chan G, Balaratnasingam C, Xu J, Mammo Z,
Han S, Mackenzie P, Merkur A, Kirker A, Albiani D, Sarunic MV and
Yu DY: In vivo optical imaging of human retinal capillary networks
using speckle variance optical coherence tomography with
quantitative clinico-histological correlation. Microvasc Res.
100:32–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Mansoori T, Sivaswamy J, Gamalapati JS,
Agraharam SG and Balakrishna N: Measurement of radial peripapillary
capillary density in the normal human retina using optical
coherence tomography angiography. J Glaucoma. 26:241–246. 2017.
View Article : Google Scholar
|
|
100
|
Jo YH, Sung KR and Yun SC: The
relationship between peripapillary vascular density and visual
field sensitivity in primary open-angle and angle-closure glaucoma.
Invest Ophthalmol Vis Sci. 59:5862–5867. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Liu G, Wang Y and Gao P: Distributions of
radial peripapillary capillary density and correlations with
retinal nerve fiber layer thickness in normal subjects. Med Sci
Monit. 27:e9336012021. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Zhuang X, Su Y, Li M, Zhang L, Mi L, Ji Y,
Deng F, Xiao O, Zhang X, Zhou L, et al: A prospective observation
of influence of anti-VEGF on optic disc vasculature in nAMD
patients. Photodiagnosis Photodyn Ther. 45:1038632024. View Article : Google Scholar
|
|
103
|
Dugel PU, Singh RP, Koh A, Ogura Y,
Weissgerber G, Gedif K, Jaffe GJ, Tadayoni R, Schmidt-Erfurth U and
Holz FG: HAWK and HARRIER: Ninety-Six-week outcomes from the phase
3 trials of brolucizumab for neovascular age-related macular
degeneration. Ophthalmology. 128:89–99. 2021. View Article : Google Scholar
|
|
104
|
Holz FG, Dugel PU, Weissgerber G, Hamilton
R, Silva R, Bandello F, Larsen M, Weichselberger A, Wenzel A,
Schmidt A, et al: Single-Chain antibody fragment VEGF inhibitor
RTH258 for neovascular age-related macular degeneration: A
randomized controlled study. Ophthalmology. 123:1080–1089. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Dugel PU, Jaffe GJ, Sallstig P, Warburton
J, Weichselberger A, Wieland M and Singerman L: Brolucizumab versus
aflibercept in participants with neovascular age-related macular
degeneration: A randomized trial. Ophthalmology. 124:1296–1304.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Lee K, Bae HW, Lee SY, Seong GJ and Kim
CY: Hierarchical cluster analysis of peripapillary retinal nerve
fiber layer damage and macular ganglion cell loss in open angle
glaucoma. Korean J Ophthalmol. 34:56–66. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Hollands H, Johnson D, Hollands S, Simel
DL, Jinapriya D and Sharma S: Do findings on routine examination
identify patients at risk for primary open-angle glaucoma? The
rational clinical examination systematic review. JAMA.
309:2035–2042. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Rud'ko AS, Budzinskaya MV, Andreeva IV,
Karpilova MA and Smirnova TV: Effect of intravitreal injections of
ranibizumab and aflibercept on the retinal nerve fiber layer in
patients with concomitant neovascular age-related macular
degeneration and glaucoma. Vestn Oftalmol. 135:177–183. 2019.In
Russian. View Article : Google Scholar
|
|
109
|
Kopić A, Biuk D, Barać J, Vinković M,
Benašić T and Kopić V: Retinal nerve fiber layer thickness in
glaucoma patients treated with multiple intravitreal anti-Vegf
(Bevacizumab) injections. Acta Clin Croat. 56:406–414. 2017.
|
|
110
|
Hwang DJ, Lee EJ, Lee SY, Park KH and Woo
SJ: Effect of diabetic macular edema on peripapillary retinal nerve
fiber layer thickness profiles. Invest Ophthalmol Vis Sci.
55:4213–4219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Yau GL, Campbell RJ, Li C and Sharma S:
Peripapillary RNFL thickness in nonexudative versus chronically
treated exudative age-related macular degeneration. Can J
Ophthalmol. 50:345–349. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Yang HS, Woo JE, Kim MH, Kim DY and Yoon
YH: Co-Evaluation of peripapillary RNFL thickness and retinal
thickness in patients with diabetic macular edema: RNFL
misinterpretation and its adjustment. PLoS One. 12:e01703412017.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Fong DS, Ferris FL III, Davis MD and Chew
EY: Causes of severe visual loss in the early treatment diabetic
retinopathy study: ETDRS report no. 24. Early treatment diabetic
retinopathy study research group. Am J Ophthalmol. 127:137–141.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Viggiano P, Grassi MO, Bisceglia G, Boscia
G, Borrelli E, Malerba MG, Fracchiolla A, Alessio G and Boscia F:
Short-term peripapillary structural and vascular changes following
anti-VEGF vs. Dexamethasone intravitreal therapy in patients with
DME. Eur J Ophthalmol. 33:2236–2242. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Photocoagulation for diabetic macular
edema. Early treatment diabetic retinopathy study report number 1.
Early treatment diabetic retinopathy study research group. Arch
Ophthalmol. 103:1796–1806. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Scott IU, Danis RP, Bressler SB, Bressler
NM, Browning DJ and Qin H; Diabetic Retinopathy Clinical Research
Network: Effect of focal/grid photocoagulation on visual acuity and
retinal thickening in eyes with non-center-involved diabetic
macular edema. Retina. 29:613–617. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Eren S, Ozturk T, Yaman A, Oner H and A
OS: Retinal nerve fiber layer alterations after photocoagulation: A
prospective spectral-domain OCT study. Open Ophthalmol J. 8:82–86.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Roohipour R, Sharifian E, Moghimi S, Fard
MA, Ghassemi F, Zarei M, Davoodi S, Bazvand F and Modjtahedi BS:
The effect of panretinal photocoagulation (PRP) versus intravitreal
bevacizumab (IVB) plus PRP on peripapillary retinal nerve fiber
layer (RNFL) thickness analyzed by optical coherence tomography in
patients with proliferative diabetic retinopathy. J Ophthalmic Vis
Res. 14:157–163. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Jampol LM, Odia I, Glassman AR, Baker CW,
Bhorade AM, Han DP, Jaffe GJ, Melia M, Bressler NM and Tanna AP;
Diabetic Retinopathy Clinical Research Network: Panretinal
photocoagulation versus ranibizumab for proliferative diabetic
retinopathy: Comparison of peripapillary retinal nerve fiber layer
thickness in a randomized clinical trial. Retina. 39:69–78. 2019.
View Article : Google Scholar :
|
|
120
|
Shin YI, Lim HB, Koo H, Lee WH and Kim JY:
Longitudinal changes in the peripapillary retinal nerve fiber layer
thickness in the fellow eyes of unilateral retinal vein occlusion.
Sci Rep. 10:77082020. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Klein R, Klein BE, Moss SE and Meuer SM:
The epidemiology of retinal vein occlusion: The beaver dam eye
study. Trans Am Ophthalmol Soc. 98:133–141. 2000.
|
|
122
|
Hahn P and Fekrat S: Best practices for
treatment of retinal vein occlusion. Curr Opin Ophthalmol.
23:175–181. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Pulido JS, Flaxel CJ, Adelman RA, Hyman L,
Folk JC and Olsen TW: Retinal vein occlusions preferred practice
pattern (®) guidelines. Ophthalmology. 123:P182–P208. 2016.
View Article : Google Scholar
|
|
124
|
Zhang M, Liu Y, Song M, Yu Y, Ruan S,
Zheng K, Wang F and Sun X: Intravitreal dexamethasone implant has
better retinal perfusion than anti-vascular endothelial growth
factor treatment for macular edema secondary to retinal vein
occlusion: A five-year real-world study. Ophthalmic Res.
66:247–258. 2023. View Article : Google Scholar
|
|
125
|
Ahn J and Hwang DD: Peripapillary retinal
nerve fiber layer thickness in patients with unilateral retinal
vein occlusion. Sci Rep. 11:181152021. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Goda I, Saliem EA, Mostafa SM, Amin AM,
Omran MY, Eltantawy B, Soliman HB, Abu El-Wafa EG, Abdelgbar AA,
Osman HO, et al: Longitudinal changes in peri-papillary retinal
nerve fiber layer thickness in patients with unilateral branch
retinal vein occlusion. Med Hypothesis Discov Innov Ophthalmol.
12:62–69. 2023. View Article : Google Scholar
|
|
127
|
Moleiro AF, Godinho G, Madeira C, Pereira
AF, Brandão E, Falcão-Reis F, Beato JN and Penas S: Peripapillary
and subfoveal choroidal thickness in retinal vein occlusions. Clin
Ophthalmol. 16:3775–3783. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Munk MR, Ceklic L, Stillenmunkes R,
Chaudhary V, Waheed N, Chhablani J, de Smet MD and Tillmann A:
Integrated assessment of OCT, multimodal imaging, and cytokine
markers for predicting treatment responses in retinal vein
occlusion associated macular edema: A comparative review of
Anti-VEGF and steroid therapies. Diagnostics (Basel). 14:19832024.
View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Shin YI, Nam KY, Lee SE, Lim HB, Lee MW,
Jo YJ and Kim JY: Changes in peripapillary microvasculature and
retinal thickness in the fellow eyes of patients with unilateral
retinal vein occlusion: An OCTA study. Invest Ophthalmol Vis Sci.
60:823–829. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Qiu Y, Sun T, Xu F, Gao P, Tang G and Peng
Q: Correlation of vascular change and cognitive impairment in
age-related macular degeneration patients. Am J Transl Res.
13:336–348. 2021.PubMed/NCBI
|
|
131
|
Fontaine O, Olivier S, Descovich D,
Cordahi G, Vaucher E and Lesk MR: The effect of intravitreal
injection of bevacizumab on retinal circulation in patients with
neovascular macular degeneration. Invest Ophthalmol Vis Sci.
52:7400–7405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Kato N, Haruta M, Furushima K, Arai R,
Matsuo Y and Yoshida S: Decrease in ocular blood flow thirty
minutes after intravitreal injections of brolucizumab and
aflibercept for neovascular age-related macular degeneration. Clin
Ophthalmol. 17:1187–1192. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Mursch-Edlmayr AS, Luft N, Podkowinski D,
Ring M, Schmetterer L and Bolz M: Effects of three intravitreal
injections of aflibercept on the ocular circulation in eyes with
age-related maculopathy. Br J Ophthalmol. 104:53–57. 2020.
View Article : Google Scholar
|
|
134
|
Mursch-Edlmayr AS, Luft N, Podkowinski D,
Ring M, Schmetterer L and Bolz M: Short-term effect on the ocular
circulation induced by unilateral intravitreal injection of
aflibercept in age-related maculopathy. Acta Ophthalmol.
97:e927–e932. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Ding X, Lu L, Yang J, Chen Y and Ma J: The
peripapillary retinal capillary density is highly correlated with
its nerve fibre layer in normal population. Clin Hemorheol
Microcirc. 74:231–239. 2020. View Article : Google Scholar
|
|
136
|
Jager RD, Mieler WF and Miller JW:
Age-related macular degeneration. N Engl J Med. 358:2606–2617.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Sakurada Y, Nakamura Y, Yoneyama S,
Mabuchi F, Gotoh T, Tateno Y, Sugiyama A, Kubota T and Iijima H:
Aqueous humor cytokine levels in patients with polypoidal choroidal
vasculopathy and neovascular age-related macular degeneration.
Ophthalmic Res. 53:2–7. 2015. View Article : Google Scholar
|
|
138
|
Obeng-Aboagye E, Frimpong A, Amponsah JA,
Danso SE, Owusu EDA and Ofori MF: Inflammatory cytokines as
potential biomarkers for early diagnosis of severe malaria in
children in Ghana. Malar J. 22:2202023. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Pessoa B, Melo-Beirão J, Meireles A and
Menéres P: Challenging clinical cases-a walk through supplemental
therapy with intravitreal ranibizumab therapy following treatment
of diabetic macular edema with the 0.19 mg fluocinolone acetonide
implant (ILUVIEN®. Int Med Case Rep J. 13:437–448.
2020.
|
|
140
|
Barash A, Chui TYP, Garcia P and Rosen RB:
Acute macular and peripapillary angiographic changes with
intravitreal injections. Retina. 40:648–656. 2020. View Article : Google Scholar
|
|
141
|
Baek SU, Park IW and Suh W: Long-term
intraocular pressure changes after intravitreal injection of
bevacizumab. Cutan Ocul Toxicol. 35:310–314. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Zeng L, Liu X, Chen S and Ma J:
Quantitative analysis of peripapillary capillary volume using dense
B-scan OCT angiography in normal and diabetic retina. Eye Vis
(Lond). 11:342024. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Li Y, Busoy JM, Zaman BAA, Tan QSW, Tan
GSW, Barathi VA, Cheung N, Wei JJ, Hunziker W, Hong W, et al: A
novel model of persistent retinal neovascularization for the
development of sustained anti-VEGF therapies. Exp Eye Res.
174:98–106. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Gross JG, Glassman AR, Jampol LM, Inusah
S, Aiello LP, Antoszyk AN, Baker CW, Berger BB, Bressler NM,
Browning D, et al: Panretinal photocoagulation vs intravitreous
ranibizumab for proliferative diabetic retinopathy: A randomized
clinical trial. JAMA. 314:2137–2146. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Reddy SV and Husain D: Panretinal
photocoagulation: A review of complications. Semin Ophthalmol.
33:83–88. 2018. View Article : Google Scholar
|
|
146
|
Soman M, Ganekal S, Nair U and Nair K:
Effect of panretinal photocoagulation on macular morphology and
thickness in eyes with proliferative diabetic retinopathy without
clinically significant macular edema. Clin Ophthalmol. 6:2013–2017.
2012.PubMed/NCBI
|
|
147
|
Helmy AMR, Rashad MA, Gharieb HM, Gomaa WA
and Zaki RGE: Optic nerve head perfusion changes in eyes with
proliferative diabetic retinopathy treated with intravitreal
ranibizumab or photocoagulation: A randomized controlled trial. Med
Hypothesis Discov Innov Ophthalmol. 11:144–150. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Fan L, Zhu Y, Sun X, Yu J and Yan H:
Patients with unilateral retinal vein occlusion show reduced radial
peripapillary capillary density in their fellow eyes. BMC
Ophthalmol. 21:4482021. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Wang Q, Chan SY, Yan Y, Yang J, Zhou W,
Jonas JB and Wei WB: Optical coherence tomography angiography in
retinal vein occlusions. Graefes Arch Clin Exp Ophthalmol.
256:1615–1622. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Finkelstein D: Argon laser
photocoagulation for macular edema in branch vein occlusion.
Ophthalmology. 93:975–977. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Hayashi K and Hayashi H: Intravitreal
versus retrobulbar injections of triamcinolone for macular edema
associated with branch retinal vein occlusion. Am J Ophthalmol.
139:972–982. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Kumagai K, Furukawa M, Ogino N, Uemura A
and Larson E: Long-term outcomes of vitrectomy with or without
arteriovenous sheathotomy in branch retinal vein occlusion. Retina.
27:49–54. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Ehlers JP, Kim SJ, Yeh S, Thorne JE,
Mruthyunjaya P, Schoenberger SD and Bakri SJ: Therapies for macular
edema associated with branch retinal vein occlusion: A report by
the american academy of ophthalmology. Ophthalmology.
124:1412–1423. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Liu S: Effect of anti-VEGF therapy on
optic disc microcirculation in patients with macular edema
secondary to branch retinal vein occlusion based on OCTA. MA
thesis. Gannan Medical College; Gannan: pp. 16–21. 2022, In
Chinese.
|
|
155
|
Sun J: The changes of radial peripapillary
capillary density before and after anti-VEGF treatments in patients
with branch retinal vein occlusion complicated with macular edema
were evaluated by OCTA. MA thesis. Chengde Medical College;
Chengde: pp. 17–22. 2022, In Chinese.
|
|
156
|
Tan C: Detection and correlation analysis
of microvessel density and nerve fiber layer thickness in optic
disc before and after anti-vascular endothelial growth factor
treatment in patients with retinal vein occlusion. MA thesis.
Bengbu Medical College; Bengbu: pp. 25–30. 2021, In Chinese.
|
|
157
|
Nicolai M, Franceschi A, Turris S, Rosati
A, Pirani V and Mariotti C: Papillary vessel density changes after
intravitreal Anti-VEGF injections in hypertensive patients with
central retinal vein occlusion: An angio-OCT study. J Clin Med.
8:16362019. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Asano T, Kunikata H, Yasuda M, Nishiguchi
KM, Abe T and Nakazawa T: Ocular microcirculation changes, measured
with laser speckle flowgraphy and optical coherence tomography
angiography, in branch retinal vein occlusion with macular edema
treated by ranibizumab. Int Ophthalmol. 41:151–162. 2021.
View Article : Google Scholar
|
|
159
|
Nagasato D, Mitamura Y, Semba K, Akaiwa K,
Nagasawa T, Yoshizumi Y, Tabuchi H and Kiuchi Y: Correlation
between optic nerve head circulation and visual function before and
after anti-VEGF therapy for central retinal vein occlusion:
Prospective, interventional case series. BMC Ophthalmol. 16:362016.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Fukami M, Iwase T, Yamamoto K, Kaneko H,
Yasuda S and Terasaki H: Changes in retinal microcirculation after
intravitreal ranibizumab injection in eyes with macular edema
secondary to branch retinal vein occlusion. Invest Ophthalmol Vis
Sci. 58:1246–1255. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Toto L, Evangelista F, Viggiano P, Erroi
E, D'Onofrio G, Libertini D, Porreca A, D'Aloisio R, Mariacristina
P, Di Antonio L, et al: Changes in ocular blood flow after
ranibizumab intravitreal injection for diabetic macular edema
measured using laser speckle flowgraphy. Biomed Res Int.
2020:94962422020. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Mizukami T, Mizumoto S, Ishibashi T, Ueno
S, Toyonishi T, Tachibana K, Mishima S and Shimomura Y: Changes in
ocular blood flow after intravitreal injection for diabetic macular
edema between aflibercept and faricimab. Clin Ophthalmol.
18:2407–2416. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Consigli A, Papanastasiou A, Roquelaure D,
Wuarin R, Roy S, Thumann G and Chronopoulos A: Changes in retinal
vascular caliber after intravitreal aflibercept treatment for
diabetic macular oedema. Klin Monbl Augenheilkd. 236:1318–1324.
2019.In German.
|
|
164
|
Förstermann U and Sessa WC: Nitric oxide
synthases: Regulation and function. Eur Heart J. 33:829–837. 2012.
View Article : Google Scholar :
|
|
165
|
Thulliez M, Angoulvant D, Lez ML,
Jonville-Bera AP, Pisella PJ, Gueyffier F and Bejan-Angoulvant T:
Cardiovascular events and bleeding risk associated with
intravitreal antivascular endothelial growth factor monoclonal
antibodies: Systematic review and meta-analysis. JAMA Ophthalmol.
132:1317–1326. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Fung AE, Rosenfeld PJ and Reichel E: The
international intravitreal bevacizumab safety survey: Using the
internet to assess drug safety worldwide. Br J Ophthalmol.
90:1344–1349. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Kitchens JW, Do DV, Boyer DS, Thompson D,
Gibson A, Saroj N, Vitti R, Berliner AJ and Kaiser PK:
Comprehensive review of ocular and systemic safety events with
intravitreal aflibercept injection in randomized controlled trials.
Ophthalmology. 123:1511–1520. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Buyukavsar C, Sonmez M, Sagdic SK and Unal
MH: Relationship between ganglion cell complex thickness and vision
in age-related macular degeneration treated with aflibercept. Eur J
Ophthalmol. 33:1672–1682. 2023. View Article : Google Scholar
|
|
169
|
Dziedziak J, Zaleska-Żmijewska A, Szaflik
JP and Cudnoch-Jędrzejewska A: Impact of arterial hypertension on
the eye: A review of the pathogenesis, diagnostic methods, and
treatment of hypertensive retinopathy. Med Sci Monit.
28:e9351352022. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Kiyat P and Karti O: Comparison of
choroidal vascularity index, retinal, and optic nerve changes in
diabetes mellitus patients without diabetic retinopathy. Beyoglu
Eye J. 9:228–234. 2024. View Article : Google Scholar
|
|
171
|
Swaminathan SS, Jammal AA, Berchuck SI and
Medeiros FA: Rapid initial OCT RNFL thinning is predictive of
faster visual field loss during extended follow-up in glaucoma. Am
J Ophthalmol. 229:100–107. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Kim MJ, Woo SJ, Park KH and Kim TW:
Retinal nerve fiber layer thickness is decreased in the fellow eyes
of patients with unilateral retinal vein occlusion. Ophthalmology.
118:706–710. 2011. View Article : Google Scholar
|
|
173
|
Qin HF, Shi FJ, Zhang CY, Luo DW, Qin SY,
Wu J, Xie H, Zhang JT, Qiu QH, Liu K, et al: Anti-VEGF reduces
inflammatory features in macular edema secondary to retinal vein
occlusion. Int J Ophthalmol. 15:1296–1304. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Imazeki M, Noma H, Yasuda K, Motohashi R,
Goto H and Shimura M: Anti-VEGF therapy reduces inflammation in
diabetic macular edema. Ophthalmic Res. 64:43–49. 2021. View Article : Google Scholar
|
|
175
|
Nakao S, Arima M, Ishikawa K, Kohno R,
Kawahara S, Miyazaki M, Yoshida S, Enaida H, Hafezi-Moghadam A,
Kono T and Ishibashi T: Intravitreal anti-VEGF therapy blocks
inflammatory cell infiltration and re-entry into the circulation in
retinal angiogenesis. Invest Ophthalmol Vis Sci. 53:4323–4328.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Nishijima K, Ng YS, Zhong L, Bradley J,
Schubert W, Jo N, Akita J, Samuelsson SJ, Robinson GS, Adamis AP
and Shima DT: Vascular endothelial growth factor-A is a survival
factor for retinal neurons and a critical neuroprotectant during
the adaptive response to ischemic injury. Am J Pathol. 171:53–67.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Zhang J, Zhang Z, Jiang L, He S, Long X
and Zheng X: Combination therapy with N-Acetylserotonin and
aflibercept activated the Akt/Nrf2 pathway to inhibit apoptosis and
oxidative stress in rats with retinal ischemia-reperfusion injury.
Curr Eye Res. 4:280–287. 2024. View Article : Google Scholar
|
|
178
|
Rani EA, Janani R, Chonche MJ and
Vallikannan B: Lactucaxanthin regulates the cascade of retinal
oxidative stress, endoplasmic reticulum stress and inflammatory
signaling in diabetic rats. Ocul Immunol Inflamm. 31:320–328. 2023.
View Article : Google Scholar
|
